Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Experienced Analyst Claims to Have Detected a Bullish Signal for Bitcoin, Ethereum, XRP, and Solana

Experienced Analyst Claims to Have Detected a Bullish Signal for Bitcoin, Ethereum, XRP, and Solana

BitcoinSistemiBitcoinSistemi2026/07/01 17:39
By:BitcoinSistemi

Crypto analyst Ali Martinez said that signals indicating a long-term market reversal are emerging in major crypto assets, particularly Bitcoin. According to Martinez, the Tom DeMark (TD) Sequential indicator is giving a bullish signal for Bitcoin, Ethereum, XRP, and Solana on the monthly charts.

The analyst noted that trend exhaustion signals, especially those seen in higher timeframes like monthly charts, are significant. Martinez stated that in the past, multiple major crypto assets simultaneously generating monthly bullish signals indicated seller fatigue and long-term market lows.

Another data point highlighted by Martinez concerned the profit and loss status of Bitcoin’s supply. According to the analyst, for the first time in this cycle, the amount of Bitcoin held at a loss reached 10.45 million BTC, surpassing the 9.60 million BTC held at a profit.

Martinez said that the fact that more than half of the circulating Bitcoin supply is at a loss indicates that the speculative bubble in the market has largely cleared. The analyst argued that such crossovers have only been seen very close to major cycle bottoms in Bitcoin’s 15-year history.

Looking at past examples, a similar intersection first occurred in September 2011, and Bitcoin bottomed out in November 2011, starting a new bull market. The second intersection took place in September 2014, and after the market consolidated under these conditions until October 2015, it entered a new expansion period.

The third intersection, seen in November 2018, coincided with one of the harshest periods of the bear market. Following this, Bitcoin began a new bull cycle in March 2019. A similar intersection occurred during the liquidity crisis of March 2020, but this lasted only 17 days, and Bitcoin recorded a strong recovery by April 2020.

According to Martinez, the first supply intersection of the current cycle officially occurred in June 2026, and the metrics have continued to move in the opposite direction since then. The analyst argued that while such periods have lasted from a few weeks to a few months in past data, Bitcoin is currently trading in a region of high-reliability accumulation.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The "Outlier" Investment Art in the New Era of Berky

他山之石观投资2026/09/14 09:22
The "Outlier" Investment Art in the New Era of Berky

Chevron (CVX.US) explores alternative hedging for Middle East supply disruptions: targets Argentina and the Mediterranean to drive global LNG growth, seeks deal with India

Chevron is focusing on Argentina and the Mediterranean region, seeking global growth in liquefied natural gas, and plans to reach an agreement with India.

智通财经2026/09/14 09:12
Chevron (CVX.US) explores alternative hedging for Middle East supply disruptions: targets Argentina and the Mediterranean to drive global LNG growth, seeks deal with India

Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge

The upward pressure on energy prices caused by the unresolved Middle East war is mounting. New risks are also approaching, which may keep inflation above the Bank of England’s 2% target for most of next year.

智通财经2026/09/14 08:57
Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge

AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales

Bloomberg Intelligence analyst John Murphy stated that the setback in AstraZeneca's breast cancer drug trial could reduce sales in 2035 by $2.6 billion to $3.8 billion.

智通财经2026/09/14 08:41
AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales